BRIEF published on 08/27/2026 at 19:04, 21 hours 17 minutes ago ABIONYX Pharma fait le point sur ses résultats financiers de mi-année 2026 Mise À Jour Financière Ophtalmologie ABIONYX Pharma Position De Trésorerie Recettes De 2026
BRIEF published on 08/27/2026 at 19:04, 21 hours 17 minutes ago ABIONYX Pharma Updates on Mid-Year 2026 Financials Cash Position Financial Update Ophthalmology ABIONYX Pharma 2026 Revenue
PRESS RELEASE published on 08/27/2026 at 18:59, 21 hours 22 minutes ago Informations privilégiées / Autres communiqués ABIONYX Pharma révèle un chiffre d’affaires consolidé de 1,9 M€ et une trésorerie de 26,9 M€ au 30 juin 2026. La société biopharmaceutique annonce des résultats financiers et une avancée dans le développement de thérapies innovantes Chiffre D'affaires Développement Trésorerie ABIONYX Pharma Thérapies Innovantes
PRESS RELEASE published on 08/27/2026 at 18:59, 21 hours 22 minutes ago Inside Information / Other news releases ABIONYX Pharma updates activity and cash position for H1 2026: revenue of €1.9M, cash balance of €26.9M before Research Tax Credits and grants. Company focuses on innovative therapies for sepsis Revenue Cash Position Innovative Therapies ABIONYX Pharma Activity Update
BRIEF published on 07/06/2026 at 20:05, 1 month 21 days ago ABIONYX Monthly Voting Rights Update Euronext Paris Share Capital Voting Rights Financial Update ABIONYX Pharma
BRIEF published on 07/06/2026 at 20:05, 1 month 21 days ago ABIONYX : Détails sur le Capital Social et les Droits de Vote Euronext Paris Droits De Vote Capital Social AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 1 month 21 days ago ABIONYX: Details on Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 1 month 21 days ago Mise à jour mensuelle d'ABIONYX sur les droits de vote Euronext Paris Capital Social Droit De Vote Mise À Jour Financière ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 20:00, 1 month 21 days ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares. Company focuses on innovative medicines development with lipid science expertise Shares Total Voting Rights ABIONYX Pharma Innovative Medicines Lipid Science
PRESS RELEASE published on 07/06/2026 at 20:00, 1 month 21 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique les informations sur son capital social et ses droits de vote, avec 42 568 071 actions en circulation le 30 juin 2026 Droits De Vote Développement Capital Social Biopharma ABIONYX Pharma
Published on 08/28/2026 at 14:00, 2 hours 21 minutes ago Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 3 hours 21 minutes ago Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 8 hours 16 minutes ago Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 8 hours 16 minutes ago Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 8 hours 21 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate
Published on 08/28/2026 at 15:55, 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: DNO Iraq AS (a wholly owned subsidiary of DNO ASA)
Published on 08/28/2026 at 15:54, 26 minutes ago Viromed Medical AG receives ÜTS registration for ViroCAP® in Turkey and can fulfill existing orders
Published on 08/26/2026 at 18:02, 1 day 22 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 1 day 22 hours ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 1 day 22 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
